contact@tendernotify.co.uk
Back to suppliers

NOVARTIS PHARMACEUTICALS UK LIMITED

Total awarded
£624,568,746
NHS National Branded Interim - 1 June 2026
10 Apr 2026 £529,090,780
NHS National Framework Agreement for Omalizumab
26 Nov 2025 £87,433,000
REVOLADE (ELTROMBOPAG) TABLETS, 28 tablet
£1,000,000
Utathera 7400MBq/20.5-25ml solution
solution for infusion vial
TRAMETINIB 2MG TABLETS, 30 tablet, pack
£270,000
Contract for Netspot (Gallium Ga 68 Dotatate)
£316,800
SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection
£4,638,166
PRRT (Peptide Receptor Radionuclide Therapy)
£1,820,000
NHS National Framework for Transition products (Axitinib and Eltrombopag)
MIDOSTAURIN 25MG CAPSULES
Canakinumab